Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.